Autism Research Project With Non-Invasive Near-Infrared Light Stimulation
Launched by UNIVERSITY OF TEXAS AT AUSTIN · Jan 2, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
The Autism Research Project is studying a treatment called low-level light therapy, which uses safe and gentle infrared light to help improve thinking, emotions, and brain activity. Researchers believe this method could help reduce some of the behavioral challenges faced by individuals with Autism Spectrum Disorder (ASD). The trial is currently looking for participants aged between 4 and 60 years old, and it is open to everyone, regardless of gender.
If you or someone you know is interested in participating, it’s important to note that pregnant individuals cannot join the study. Participants will receive this non-invasive light treatment and will be monitored to see how it affects their symptoms. This project aims to provide new insights into how light therapy might benefit those with ASD, and your involvement could contribute to important research in this area.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 4-60 years
- Exclusion Criteria:
- • Current pregnancy
About University Of Texas At Austin
The University of Texas at Austin, a leading research institution, is dedicated to advancing knowledge and innovation in the field of healthcare through rigorous clinical trials. Known for its commitment to scientific excellence, the university leverages its diverse expertise and cutting-edge facilities to conduct research that addresses critical health challenges. Collaborating with a multidisciplinary team of researchers, clinicians, and students, the University of Texas at Austin aims to translate scientific discoveries into effective treatments and interventions, ultimately enhancing patient outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Austin, Texas, United States
Patients applied
Trial Officials
Sarah W Diaz, PhD
Study Director
University of Texas at Austin
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported